Can an inhaled drug ease bronchiectasis? a trial seeks answers
Disease control
Not yet recruiting
This trial tests an inhaled investigational drug called ALX1 in adults with bronchiectasis, a chronic lung condition that causes coughing and mucus buildup. Participants receive either ALX1 or a placebo for 14 days. The study aims to find safe and effective doses for future resea…
Phase: PHASE2 • Sponsor: Vast Therapeutics • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC